Diablo Eye Associates
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma (NCT05583591) | Diablo Eye Associates | 2022-10-01 |
Track Diablo Eye Associates automatically
Every clearance here is in the API, with alerts when new ones post.